What does this LOINC code represent?

This LOINC code identifies a lab observation, measurement, question, or clinical concept in a standardized format.

Is this enough to understand my test result?

No. The code identifies the test or observation, but the interpretation depends on the actual result, reference range, and clinical context.

LOINCActiveBoth

LOINC Code 98854-3: Urothelial carcinoma probability score based on clinical and lab data

Name: LOINC Code 98854-3: Urothelial carcinoma probability score based on clinical and lab data
Creator: HealthAssure Clinical Team
Published: 2026-05-21T09:00:33.063Z

98854-3 is a LOINC code used to identify Urothelial carcinoma probability score based on clinical and lab data in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Urothelial carcinoma probability score. It is commonly used with the system or sample type Urine.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Urothelial carcinoma probability score. It is commonly used with the system or sample type Urine.

When is it used?

Used in lab systems, EHRs, and clinical data exchange.
May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
Status: ACTIVE
Order vs observation: Both
Method: Based on clinical+lab data

What it does not mean

The code identifies the observation or test, not the actual result.

Key facts

Urothelial carcinoma probability score based on clinical and lab data

Urothelial carcinoma probability score

The likelihood that a patient will have urothelial carcinoma based on lab and clinical data. Urine-derived biomarkers may be used along with additional phenotypic and clinical risk factors to identify patients with hematuria who have a low probability of bladder cancer and may not require a more extensive urological evaluation. To report the algorithm used to determine the urothelial carcinoma probability score, use Risk calculation method used [LOINC94561-8].

Bladder cancer; CLIN.RISK; from clin+lab data; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Scre; UA; UR; Urn; Urothelial carcinoma prob score

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Urothelial carcinoma probability score based on clinical and lab dataUrothelial Ca prob score clin+lab dataUrothelial carcinoma probability scoreCLIN.RISKScorePtUrine

Frequently asked questions

Code details

Code98854-3

SystemLOINC

Display nameUrothelial carcinoma probability score based on clinical and lab data

DescriptionUrothelial carcinoma probability score

Short nameUrothelial Ca prob score clin+lab data

ComponentUrothelial carcinoma probability score

PropertyScore

TimingPt

System (specimen)Urine

ScaleQn

MethodBased on clinical+lab data

ClassCLIN.RISK

Example unitsscore

StatusACTIVE

Order/ObservationBoth

Flags

BillableNo

Valid clinical useNo

Source

SourceLOINC

Version2.82

Releasemain

First released2.72

Last changed2.72

Part names

Urothelial carcinoma probability scoreScorePtUrineQnBased on clinical+lab dataPoint in time (spot)Based on clinical and lab data

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.